Condition

Pneumonitis

ClinicalTrials.gov condition label

Clinical trials8

Recruiting1

Common interventions10

Lead sponsors shown8

Clinical trials

8 shown

Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation TherapyNCT06688422 · 2024-12-01

Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIPNCT05280873 · 2021-10-10

Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence (COVID-19)NCT04721444 · 2021-01-27

Tocilizumab for Patients With Cancer and COVID-19 DiseaseNCT04370834 · 2020-05-28

Exhaled Breath Analysis to Predict Risk of Symptomatic PneumonitisNCT04040244 · 2019-12-09

Everolimus Related Pneumonitis in MBCNCT03730428 · 2017-07-15

Study of Collagen IV and XIX in Bronchoalveolar Lavage, Pulmonary Aspiration and Bronchial BiopsiesNCT02788643 · 2014-05-01

Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung CancerNCT00081315 · 2003-11-01

Common interventions

AmifostineDRUG1 biological fluids (serum, bronchoalveolar lavage and pulmonary aspiration) and bronchial biopsies collectionBIOLOGICAL1 Blood sampleOTHER1 Exhaled Breath CollectionOTHER1 incentive spirometryDEVICE1 Machine Learning Classification of parenchymal lung change causeDIAGNOSTIC_TEST1 Machine Learning Classification of recurrence and non-recurrenceDIAGNOSTIC_TEST1 MethylprednisoloneDRUG1 Pirfenidone, methylprednisoloneDRUG1 TocilizumabBIOLOGICAL1

Leading sponsors

CHU de Reims1 Fudan University1 MedImmune LLC1 National Cancer Institute (NCI)1 Royal Marsden NHS Foundation Trust1 The Cooper Health System1 Wake Forest University Health Sciences1 Zhou Chengzhi1

Trial status mix

COMPLETED4

TERMINATED2

RECRUITING1

UNKNOWN1

Phase mix

NA2

PHASE22

PHASE11

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.